SCHEMBL22006983

SCHEMBL22006983

CB(N)OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.50
AGXT P21549 3/20 0.48
TSHR P16473 1/20 0.48
ALDH1A1 P00352 2/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
LIPE Q05469 1/20 0.41
MAPT P10636 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MAOB P27338 2/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
GAA P10253 1/20 0.41
MAOA P21397 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TACR1 P25103 2/20 0.40
TP53 P04637 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132101 0.77 IDO1 (0.50) IDO1AGXTTSHRALDH1A1CA1
SCHEMBL933492 0.77 LIPE (0.50) IDO1AGXTTSHRALDH1A1CA1
SCHEMBL51017 0.75 TSHR (0.57) IDO1AGXTTSHRALDH1A1CA1
SCHEMBL3893963 0.73 TSHR (0.48) IDO1AGXTTSHRALDH1A1CA1
SCHEMBL794 0.72
SCHEMBL17333443 0.71 TSHR (0.52) IDO1AGXTTSHRALDH1A1CA1
SCHEMBL6987582 0.71 TSHR (0.52) IDO1AGXTTSHRALDH1A1CA1
SCHEMBL2025672 0.71 TSHR (0.52) IDO1AGXTTSHRALDH1A1CA1
SCHEMBL3080694 0.71 TSHR (0.52) IDO1AGXTTSHRALDH1A1CA1
Hydrochloric Acid SCHEMBL9981027 0.70 TSHR (0.57) IDO1AGXTTSHRALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200157098-A1 6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINE DOPAMINE D3 LIGANDS PFIZER (US) 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200157098-A1 6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINE DOPAMINE D3 LIGANDS DRD3, DRD2, DRD4 IDO1 248/4885AGXT 2877/4885TSHR 227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.